Atlas Trials

A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Clinical trial NCT04288778 · COMPLETED

Trial details

NCT number
NCT04288778
Sponsor
Johnson & Johnson Private Limited
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2020-11-25
Primary completion
2022-07-26
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.